These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 23109406

  • 21. Do apolipoproteins improve coronary risk prediction in subjects with metabolic syndrome? Insights from the North Italian Brianza cohort study.
    Gianfagna F, Veronesi G, Guasti L, Chambless LE, Brambilla P, Corrao G, Mancia G, Cesana G, Ferrario MM.
    Atherosclerosis; 2014 Sep; 236(1):175-81. PubMed ID: 25062081
    [Abstract] [Full Text] [Related]

  • 22. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG, Ballantyne CM, Hsueh WA, Rosen JB, Lin J, Shah AK, Tomassini JE, Lowe RS, Tershakovec AM.
    J Clin Lipidol; 2013 Sep; 7(4):292-303. PubMed ID: 23890516
    [Abstract] [Full Text] [Related]

  • 23. High absolute coronary disease risk among Turks: involvement of risk factors additional to conventional ones.
    Onat A, Can G, Hergenç G, Küçükdurmaz Z, Uğur M, Yüksel H.
    Cardiology; 2010 Sep; 115(4):297-306. PubMed ID: 20395681
    [Abstract] [Full Text] [Related]

  • 24. Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study.
    Bruno G, Merletti F, Biggeri A, Bargero G, Prina-Cerai S, Pagano G, Cavallo-Perin P.
    Diabetologia; 2006 May; 49(5):937-44. PubMed ID: 16525840
    [Abstract] [Full Text] [Related]

  • 25. Role of lipid and lipoprotein profiles in risk assessment and therapy.
    Ballantyne CM, Hoogeveen RC.
    Am Heart J; 2003 Aug; 146(2):227-33. PubMed ID: 12891189
    [Abstract] [Full Text] [Related]

  • 26. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
    Onat A, Uzunlar B, Hergenç G, Yazici M, Sari I, Uyarel H, Can G, Sansoy V.
    Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).
    Ballantyne CM, Pitt B, Loscalzo J, Cain VA, Raichlen JS.
    Am J Cardiol; 2013 Feb 15; 111(4):506-9. PubMed ID: 23237107
    [Abstract] [Full Text] [Related]

  • 30. Comparison of Apolipoprotein (ApoB/ApoA-1) and Lipoprotein (Total Cholesterol/HDL) Ratios in Obese Adolescents.
    Alemzadeh R, Kichler J.
    Metab Syndr Relat Disord; 2018 Feb 15; 16(1):40-45. PubMed ID: 29154726
    [Abstract] [Full Text] [Related]

  • 31. Association of High-Density Lipoprotein-Cholesterol Versus Apolipoprotein A-I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer-Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study.
    van Capelleveen JC, Bochem AE, Boekholdt SM, Mora S, Hoogeveen RC, Ballantyne CM, Ridker PM, Sun W, Barter PJ, Tall AR, Zwinderman AH, Kastelein JJP, Wareham NJ, Khaw KT, Hovingh GK.
    J Am Heart Assoc; 2017 Aug 03; 6(8):. PubMed ID: 28775061
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Apolipoproteins and long-term prognosis in coronary heart disease patients.
    Benderly M, Boyko V, Goldbourt U.
    Am Heart J; 2009 Jan 03; 157(1):103-10. PubMed ID: 19081405
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals.
    Voulgari C, Tentolouris N, Dilaveris P, Tousoulis D, Katsilambros N, Stefanadis C.
    J Am Coll Cardiol; 2011 Sep 20; 58(13):1343-50. PubMed ID: 21920263
    [Abstract] [Full Text] [Related]

  • 37. Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes.
    Taskinen MR, Barter PJ, Ehnholm C, Sullivan DR, Mann K, Simes J, Best JD, Hamwood S, Keech AC, FIELD study investigators.
    Diabetologia; 2010 Sep 20; 53(9):1846-55. PubMed ID: 20526762
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.